Home › Aplastic Anemia › Georgia › Atlanta
Aplastic Anemia clinical trials in Atlanta, GA
4 studies for Aplastic Anemia are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
The HOPE Biobank Resource (BMT CTN 2402 HOPE)
RecruitingObservational studyHealthy volunteers welcome
- Children's Healthcare of Atlanta, Atlanta
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Children's Healthcare of Atlanta, Atlanta
- Northside Hospital, Atlanta
Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
RecruitingPhase 2
- Blood and Marrow Transplant Group of Georgia, Atlanta
- Northside Hospital, Atlanta
Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
RecruitingPhase 2
- Emory Winship Cancer Institute, Atlanta
- Blood and Marrow Transplant Center at Northside Hospital, Atlanta
About Aplastic Anemia
Aplastic anemia is a rare but serious blood disorder. If you have it, your bone marrow doesn't make enough new blood cells. Read more on the causes.
More about Aplastic Anemia on MedlinePlus
Aplastic Anemia trials in other cities
- Washington, DC8 studies
- Baldwin Park, CA5 studies
- Nashville, TN4 studies
- New York City, NY4 studies
- Milwaukee, WI4 studies
- St. Louis, MO4 studies
- Durham, NC4 studies
- Philadelphia, PA4 studies
- Detroit, MI3 studies
- Birmingham, AL3 studies
- Columbus, OH3 studies
- Houston, TX3 studies
Other studies in Atlanta
- Cancer (all types)50 studies
- Non-Small Cell Lung Cancer46 studies
- Multiple Myeloma41 studies
- Breast Cancer41 studies
- Prostate Cancer32 studies
- Lung Cancer29 studies
- Colorectal Cancer29 studies
- Acute Myeloid Leukemia29 studies
- Ovarian Cancer28 studies
- Metastatic Cancer27 studies
- Obesity25 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.